
Sign up to save your podcasts
Or


Berkeley biochemist Jennifer Doudna joins oncologist Siddartha Mukherjee to discuss unprecedented advancements in gene editing and the effect new technologies will have on the future of humanity.
Dr. Doudna’s research has led to what is being called the biggest scientific discovery of our era: the development of the genetic editing tool, CRISPR-Cas9. This revolutionary technology has quickly transformed the landscape of genome engineering, creating limitless possibilities for impact within biomedicine, agriculture, climate and energy, and more, including treating — and possibly curing — genetic diseases.
Dr. Mukherjee is a celebrated physician and researcher. His book, The Emperor of All Maladies: A Biography of Cancer, won the Pulitzer Prize for nonfiction in 2011, was named one of the 100 most influential books written in English since 1923 by TIME magazine, and was listed as one of the 100 notable books of 2010 by the New York Times magazine.
This conversation, which took place on Jan. 18, 2018, was sponsored by the Innovative Genomics Institute.
Listen and read the transcript on Berkeley News.
Hosted on Acast. See acast.com/privacy for more information.
By UC Berkeley4.8
2525 ratings
Berkeley biochemist Jennifer Doudna joins oncologist Siddartha Mukherjee to discuss unprecedented advancements in gene editing and the effect new technologies will have on the future of humanity.
Dr. Doudna’s research has led to what is being called the biggest scientific discovery of our era: the development of the genetic editing tool, CRISPR-Cas9. This revolutionary technology has quickly transformed the landscape of genome engineering, creating limitless possibilities for impact within biomedicine, agriculture, climate and energy, and more, including treating — and possibly curing — genetic diseases.
Dr. Mukherjee is a celebrated physician and researcher. His book, The Emperor of All Maladies: A Biography of Cancer, won the Pulitzer Prize for nonfiction in 2011, was named one of the 100 most influential books written in English since 1923 by TIME magazine, and was listed as one of the 100 notable books of 2010 by the New York Times magazine.
This conversation, which took place on Jan. 18, 2018, was sponsored by the Innovative Genomics Institute.
Listen and read the transcript on Berkeley News.
Hosted on Acast. See acast.com/privacy for more information.

91,066 Listeners

38,494 Listeners

6,755 Listeners

9,181 Listeners

3,994 Listeners

421 Listeners

112,601 Listeners

32,368 Listeners

187 Listeners

20 Listeners

3,739 Listeners

7,081 Listeners

16,083 Listeners

1,565 Listeners

3,436 Listeners

5,761 Listeners